CGP 4718 A, a new potential antidepressant with a dual mode of action
- 15 December 1984
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 107 (1) , 79-89
- https://doi.org/10.1016/0014-2999(84)90094-3
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Reversibility of the interaction of CGP 11305 A with MAO A in vivoEuropean Journal of Pharmacology, 1983
- Effects of CGP 11305 A, a new reversible and selective inhibitor of MAO A, on biogenic amine levels and metabolism in the rat brainNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1983
- The deamination of dopamine by human brain monoamine oxidaseNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1983
- Blockade of noradrenaline uptake by 34276-Ba, a new antidepressant drugBiochemical Pharmacology, 1971
- Confidence Set for the Ratio of Means of Two Normal Distributions when the Ratio of Variances is unknownBiometrische Zeitschrift, 1971
- Rapid method for the determination of 5‐hydroxytryptamine and 5‐hydroxyindoleacetic acid in small regions of rat brainBritish Journal of Pharmacology, 1970
- Effects of some antidepressant drugs on the depletion of intraneuronal brain catecholamine stores caused by 4,α-dimethyl-meta-tyramineEuropean Journal of Pharmacology, 1969
- Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-α-ethyl-meta-tyramineEuropean Journal of Pharmacology, 1969
- INTENSIFICATION OF THE CENTRAL SEROTONINERGIC PROCESSES AS A POSSIBLE DETERMINANT OF THE THYMOLEPTIC EFFECTPublished by Elsevier ,1969
- The Biochemistry of Affective DisordersThe British Journal of Psychiatry, 1967